BioCentury
ARTICLE | Clinical News

Dengue fever vaccine: Phase I started

August 31, 2009 7:00 AM UTC

Hawaii Biotech began a double-blind, placebo-controlled, U.S. Phase I trial to evaluate 3 doses of 10 or 50 µg intramuscular HBV-001 D1 with Alhydrogel adjuvant given once every 4 weeks in 16 healthy ...